|
1
|
Sak SD: Variants of papillary thyroid
carcinoma: Multiple faces of a familiar tumor. Turk Patoloji Derg.
31 (Suppl 1):S34–S47. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lam AK and Saremi N: Cribriform-morular
variant of papillary thyroid carcinoma: A distinctive type of
thyroid cancer. Endocr Relat Cancer. 24:R109–R121. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ambrosi F, Righi A, Ricci C, Erickson LA,
Lloyd RV and Asioli S: Hobnail variant of papillary thyroid
carcinoma: A literature review. Endocr Pathol. 28:293–301.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Stoffer SS: Werner & Ingbar's The
Thyroid: A Fundamental and Clinical Text. 7th edition. Lippincott
Williams & Wilkins, Philadelphia, PA, 1996.
|
|
5
|
Su J, Yan Y, Qu J, Xue X, Liu Z and Cai H:
Emodin induces apoptosis of lung cancer cells through ER stress and
the TRIB3/NF-κB pathway. Oncol Rep. 37:1565–1572. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li N, Wang C, Zhang P and You S: Emodin
inhibits pancreatic cancer EMT and invasion by up-regulating
microRNA-1271. Mol Med Rep. 18:3366–3374. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kim YS, Lee YM, Oh TI, Shin DH, Kim GH,
Kan SY, Kang H, Kim JH, Kim BM, Yim WJ and Lim JH: Emodin
sensitizes hepatocellular carcinoma cells to the anti-cancer effect
of sorafenib through suppression of cholesterol metabolism. Int J
Mol Sci. 19(3127)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tang Q, Wu J, Zheng F, Hann SS and Chen Y:
Emodin increases expression of insulin-like growth factor binding
protein 1 through activation of MEK/ERK/AMPKα and interaction of
PPARγ and Sp1 in lung cancer. Cell Physiol Biochem. 41:339–357.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tseng HS, Wang YF, Tzeng YM, Chen DR, Liao
YF, Chiu HY and Hsieh WT: Aloe-emodin enhances tamoxifen
cytotoxicity by suppressing Ras/ERK and PI3K/mTOR in breast cancer
cells. Am J Chin Med. 45:337–350. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tang Q, Zhao S, Wu J, Zheng F, Yang L, Hu
J and Hann SS: Inhibition of integrin-linked kinase expression by
emodin through crosstalk of AMPKα and ERK1/2 signaling and
reciprocal interplay of Sp1 and c-Jun. Cell Signal. 27:1469–1477.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yu H, Xie Y, Zhou Z, Wu Z, Dai X and Xu B:
Curcumin regulates the progression of colorectal cancer via LncRNA
NBR2/AMPK pathway. Technol Cancer Res Treat.
18(1533033819870781)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen D, Wu YX, Qiu YB, Wan BB, Liu G, Chen
JL, Lu MD and Pang QF: Hyperoside suppresses hypoxia-induced A549
survival and proliferation through ferrous accumulation via
AMPK/HO-1 axis. Phytomedicine. 67(153138)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Samuels JS, Shashidharamurthy R and
Rayalam S: Novel anti-obesity effects of beer hops compound
xanthohumol: Role of AMPK signaling pathway. Nutr Metab (Lond).
15(42)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu CC, Chen MS, Cheng YJ, Ko YC, Lin SF,
Chiu IM and Chen JY: Emodin inhibits EBV reactivation and represses
NPC tumorigenesis. Cancers (Basel). 11(1795)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tsai WL, Hsu CN and Tain YL: Whether AICAR
in pregnancy or lactation prevents hypertension programmed by high
saturated fat diet: A pilot study. Nutrients.
12(448)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hasanvand A, Amini-Khoei H, Hadian MR,
Abdollahi A, Tavangar SM, Dehpour AR, Semiei E and Mehr SE:
Anti-inflammatory effect of AMPK signaling pathway in rat model of
diabetic neuropathy. Inflammopharmacology. 24:207–219.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Guo JM, Xiao BX, Liu Q, Zhang S, Liu DH
and Gong ZH: Anticancer effect of aloe-emodin on cervical cancer
cells involves G2/M arrest and induction of differentiation. Acta
Pharmacol Sin. 28:1991–1995. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hsu LC, Tu HF, Hsu FT, Yueh PF and Chiang
IT: Beneficial effect of fluoxetine on anti-tumor progression on
hepatocellular carcinoma and non-small cell lung cancer bearing
animal model. Biomed Pharmacother. 126(110054)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yasemin S, Peterson TR, Shaul YD,
Lindquist RA, Thoreen CC, Bar-Peled L and Sabatini DM: The Rag
GTPases bind raptor and mediate amino acid signaling to mTORC1.
Science. 320:1496–1501. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hardie DG: AMPK-sensing energy while
talking to other signaling pathways. Cell Metab. 20:939–952.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Carling D: AMPK signalling in health and
disease. Curr Opin Cell Biol. 45:31–37. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Poulikakos PI, Zhang C, Bollag G, Shokat
KM and Rosen N: RAF inhibitors transactivate RAF dimers and ERK
signalling in cells with wild-type BRAF. Nature. 464:427–430.
2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lin W, Zhong M, Yin H, Chen Y, Cao Q, Wang
C and Ling C: Emodin induces hepatocellular carcinoma cell
apoptosis through MAPK and PI3K/AKT signaling pathways in
vitro and in vivo. Oncol Rep. 36:961–967.
2016.PubMed/NCBI View Article : Google Scholar
|
